logo image
search icon
Global Patient Recruitment and Retention Services Market

Patient Recruitment and Retention Services Market Size, Share & Trends Analysis Report By Type (Patient Recruitment & Registry Services, Patient Retention Services, Others), By Phases, By Disease, By Patient Age Group, By End-User, By Region, And By Segment Forecasts, 2023-2031.

Report ID : 1335 | Published : 2023-12-07 | Pages: 190 | Format: PDF/EXCEL

The Patient Recruitment and Retention Services Market Size is valued at 3.70 Billion in 2022 and is predicted to reach 5.70 Billion by the year 2031 at a 5.0 % CAGR during the forecast period for 2023-2031.

patient recruitment and retention services market

Patient recruitment and retention is an essential service for the clinical research industry, and certain developments are expected to play a significant role in the future. Patient recruitment is one of the rate-limiting stages in bringing medications to market. In addition, given the typical clinical research dropout rate, keeping patients on board is challenging. Utilizing contract service providers has been shown to hasten the patient recruiting process. In order to effectively conduct clinical research, these service providers employ a variety of outreach strategies, such as social media, mobile technologies, electronic health records (EHRs), and real-world evidence (RWE).

Retention service providers make use of different strategies such as in-house call center to address patient concerns, educational materials to keep sites engaged and study branding to encourage compliance and patient responses, creation of online and in-person support groups, electronic data capture systems, video conferencing platforms, and telemedicine tools to reduce the need for in-person visits and improve participant convenience among others

Over time, they have become increasingly significant in this process. Clinical research is conducted to learn more about the effectiveness and safety of creating new medications and medical equipment. As more people are needed for clinical trials because of regulatory and safety concerns, which are pushing trends toward longer and larger studies, the demand for patient recruiting services is increasing. The global industry has grown significantly as a result of the increasing number of clinical studies and the expanding pharmaceutical and medical industries.

With the increased complexity of clinical trials and the need for specialized patient populations for studies evaluating orphan medications and tailored therapies, several big pharma companies have outsourced their patient recruiting operations, leading to increased clinical trial costs. Delays in product release brought on by sponsors' inability to draw in and keep patients are relatively common and are considered to result in an average loss. The short suspension due to Covid-19 has significantly impacted clinical studies, especially in the area of patient recruiting.

Competitive Landscape

Some major key players in the Patient Recruitment and Retention Services Market:

  • Acurian,
  • BBK Worldwide,
  • Bright Pharmaceutical Services,
  • ClinEdge,
  • CSSi,
  • CTM,
  • Evolution Research Group (ERG),
  • Integrated Clinical Trial Services (ICTS),
  • MMG,
  • Veristat,
  • WCCT Global,
  • Antidote,
  • Clinical Accelerator,
  • Fidelis Research,
  • Ignite Data,
  • Polaris BioPharma Consulting,
  • Raremark,
  • Clinrol,
  • CROee,
  • Gitzo Medical Technology,
  • Pacific Grove

Market Segmentation:

The Patient Recruitment and Retention Services Market is segmented on the Type, Phases, Disease, Patient Age Group, and End-User. Based on Type, the market is segmented into Patient Recruitment (Recruitment, Pre-screening, Screening, & Enrolment) & Registry Services, Patient Retention Services, and Others.. Based on Disease, the market is segmented into Oncology, Infectious Disease, Endocrine/Metabolic, CNS/Neurology, Coronavirus, Cardiovascular Disease, Hematological Disorders, and Others. Based on Trial Phases, the market is segmented into Phase I, Phase II, Phase III, and Phase IV. Patient Age group segment is divided into Children and Adults whereas End-user segments consists of Hospitals, CROs, Pharma Companies, Biotech Companies, Govt organizations, and Academia.

Based on Disease, the oncology segment is accounted as a major contributor to the Patient Recruitment and Retention Services Market

The market for patient recruiting services linked to oncology is predicted to grow at a rapid pace over the forecast period. The upsurge in incidence and prevalence of various cancer disorders, the popularity of advanced therapies (such as biological and targeted pharmacological therapies), and the rising global elderly population are the main factors driving the growth of the oncology/cancer pharmaceuticals market. Additionally, the market for oncology medications is growing due to increased cancer awareness and early cancer detection. During the foreseeable period, profitable opportunities should be available due to the great potential of rising economies and the increased number of potential medications in development. The rate of advancement in cancer treatment is quickening. Emerging from the research and development pipeline are a number of novel therapies that are frequently combined with other brand-new or current medications. Numerous pharmaceutical companies are funding these revolutionary medication development projects for the treatment of cancer.

Based On Trial Phases, The Phase III Segment Is Accounted As A Major Contributor To The Patient Recruitment And Retention Services Market

The phase III category will lead the market in the forecast period with a major revenue share due to the high cost of phase III research. Complicated clinical trials need both clinical resources and potent technology for effective patient recruitment, timely deployment of trial locations, and high-quality study management. The vast majority of pharmaceutical, biopharmaceutical, and medical device companies worldwide use clinical trial service providers to conduct Phase III clinical trials. The market will expand as a result of the several medicines and vaccines that are currently in Phase III and are indicated for the treatment of COVID-19.

In The Region, The North America Patient Recruitment And Retention Services Market Holds A Significant Revenue Share.

In 2021, North America had the greatest revenue share in the worldwide market. This market is projected to grow given the numerous clinical research being conducted in the region. Government support for clinical trials and significant R&D expenditures are fostering the market's growth. The presence of significant CROs offering support services like patient recruitment and multinational pharmaceutical and biopharmaceutical companies making sizable investments in clinical research have both been credited with the growth of the North American clinical trial patient recruitment services market. The region has become a hub for conducting clinical trials due to the low cost of research, straightforward regulatory compliance, rising patient population, and availability of a few elite clinical institutions functioning as sites.

Recent Developments:

  • In Feb 2023, BBK Worldwide, the dominant force in optimizing the clinical trial experience for patients and providers, has introduced TCN® Engage, an innovative engagement system designed to offer comprehensive visit support services. This ecosystem covers the entire process, from when patients express enthusiasm for a clinical trial opportunity to their successful study completion.
  • In Oct 2023, Elligo Health Research®, the leading healthcare-facilitating research organization, has formed a collaboration with Avallano, a company specializing in data privacy and healthcare technology. They have introduced myTrialsConnectSM, an expandable research community driven by artificial intelligence (AI). This platform is designed to cater to the needs of patients, healthcare providers, research sites, and the biopharmaceutical industry.  

Patient Recruitment and Retention Services Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 3.70 Billion

Revenue Forecast In 2031

USD 5.70 Billion

Growth Rate CAGR

CAGR of 5.0 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Billion and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Type, By Phases, By Disease, By Patient Age Group, By End-User

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Acurian, BBK Worldwide, Bright Pharmaceutical Services, ClinEdge, CSSi, CTM, Evolution Research Group (ERG), Integrated Clinical Trial Services (ICTS), MMG, Veristat, WCCT Global, Antidote, Clinical Accelerator, Fidelis Research, Ignite Data, Polaris BioPharma Consulting, Raremark, Clinrol, CROee, Gitzo Medical Technology, Pacific Grove, and TrialWire.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Patient Recruitment and Retention Services Market Snapshot

Chapter 4. Global Patient Recruitment and Retention Services Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis

5.1. By Type & Market Share, 2019 & 2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Type:

5.2.1. Patient Recruitment (Recruitment, Pre-screening, Screening, & Enrolment) & Registry Services

5.2.2. Patient Retention Services

5.2.3. Others

Chapter 6. Market Segmentation 2: By Disease Estimates & Trend Analysis

6.1. By Disease & Market Share, 2019 & 2031

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Disease:

6.2.1. Oncology

6.2.2. Infectious Disease

6.2.3. Endocrine/Metabolic

6.2.4. CNS/Neurology

6.2.5. Coronavirus

6.2.6. Cardiovascular Disease

6.2.7. Hematological Disorders

6.2.8. Others

Chapter 7. Market Segmentation 3: By Phases Estimates & Trend Analysis

7.1. By Phases & Market Share, 2019 & 2031

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Phases:

7.2.1. Phase I

7.2.2. Phase II

7.2.3. Phase III

7.2.4. Phase IV

Chapter 8. Market Segmentation 4: By Patient Age Group Estimates & Trend Analysis

8.1. By Patient Age Group & Market Share, 2019 & 2031

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Patient Age Group:

8.2.1. Children

8.2.2. Adult

Chapter 9. Market Segmentation 5: By End-User Estimates & Trend Analysis

9.1. By End-User & Market Share, 2019 & 2031

9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By End-User:

9.2.1. Hospitals

9.2.2. CROs

9.2.3. Pharma Companies

9.2.4. Biotech Companies

9.2.5. Govt organizations

9.2.6. Academia

Chapter 10. Patient Recruitment and Retention Services Market Segmentation 6: Regional Estimates & Trend Analysis

10.1. North America

10.1.1. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Type, 2023-2031

10.1.2. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Disease, 2023-2031

10.1.3. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Phases, 2023-2031

10.1.4. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Patient Age Group, 2023-2031

10.1.5. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By End-User, 2023-2031

10.1.6. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts by country, 2023-2031

10.2. Europe

10.2.1. Europe Patient Recruitment and Retention Services Market revenue (US$ Million) By Type, 2023-2031

10.2.2. Europe Patient Recruitment and Retention Services Market revenue (US$ Million) By Disease, 2023-2031

10.2.3. Europe Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Phases, 2023-2031

10.2.4. Europe Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Patient Age Group, 2023-2031

10.2.5. Europe Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By End-User, 2023-2031

10.2.6 Europe Patient Recruitment and Retention Services Market revenue (US$ Million) by country, 2023-2031

10.3. Asia Pacific

10.3.1. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) By Type, 2023-2031

10.3.2. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) By Disease, 2023-2031

10.3.3. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Phases, 2023-2031

10.3.4. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Patient Age Group, 2023-2031

10.3.5. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By End-User, 2023-2031

10.3.6. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) by country, 2023-2031

10.4. Latin America

10.4.1. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) By Type, (US$ Million)

10.4.2. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) By Disease, (US$ Million)

10.4.3. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Phases, 2023-2031

10.4.4. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Patient Age Group, 2023-2031

10.4.5. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By End-User, 2023-2031

10.4.6. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) by country, 2023-2031

10.5. Middle East & Africa

10.5.1. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) By Type, (US$ Million)

10.5.2. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) By Disease, (US$ Million)

10.5.3. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Phases, 2023-2031

10.5.4. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Patient Age Group, 2023-2031

10.5.5. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By End-User, 2023-2031

10.5.6. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) by country, 2023-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Acurian

9.2.2. BBK Worldwide

9.2.3. Bright Pharmaceutical Services

9.2.4. ClinEdge

9.2.5. CSSi

9.2.6. CTM

9.2.7. Evolution Research Group (ERG)

9.2.8. Integrated Clinical Trial Services (ICTS)

9.2.9. MMG

9.2.10. Veristat

9.2.11. WCCT Global

9.2.12. Antidote

9.2.13. Clinical Accelerator

9.2.14. Fidelis Research

9.2.15. Ignite Data

9.2.16. Polaris BioPharma Consulting

9.2.17. Raremark

9.2.110. Clinrol

9.2.19. CROee

9.2.20. Gitzo Medical Technology

9.2.21. Pacific Grove

9.2.22. TrialWire

9.2.23. Other Prominent Players

 

Segmentation of Patient Recruitment and Retention Services Market-

Patient Recruitment and Retention Services Market By Type

  • Patient Recruitment (Recruitment, Pre-screening, Screening, & Enrolment) & Registry Services
  • Patient Retention Services
  • Others

Patient Recruitment and Retention Services Market

Patient Recruitment and Retention Services Market By Disease

  • Oncology
  • Infectious Disease
  • Endocrine/Metabolic
  • CNS/Neurology
  • Coronavirus
  • Cardiovascular Disease
  • Hematological Disorders
  • Others

Patient Recruitment and Retention Services Market By Phases

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Patient Recruitment and Retention Services Market By Patient Age Group

  • Children
  • Adults

Patient Recruitment and Retention Services Market By End-User

  • Hospitals
  • CROs
  • Pharma Companies
  • Biotech Companies
  • Govt organizations
  • Academia

Patient Recruitment and Retention Services Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

Who are the Key Players in the Global Patient Recruitment and Retention Services Market?

The Patient Recruitment and Retention Services Market Size is valued at 3.70 Billion in 2022 and is predicted to reach 5.70 Billion by the year 2031.

The Patient Recruitment and Retention Services Market is expected to grow at a 5.0 % CAGR during the forecast period for 2023-2031.

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach